BABA
Alibaba Group Holding Limited
BABA has lower modeled downside risk, despite its lower overall score.
FIGS
FIGS, Inc.
FIGS has the edge over BABA overall, supported by stronger fundamentals and stronger valuation.
BABA Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Under pressure | |
| Weak | |
| Healthy |
BABA's balance sheet is currently healthy, and its revenue is stable, but its profitability and cash flow are under pressure.
FIGS Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| Strong | |
| Strong |
FIGS's revenue, profitability, cash flow and balance sheet are all currently healthy.
BABA PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 16x | $69.66 | -26% |
| Fair | 20x | $86.59 | -8.2% |
| Current | 21x | $94.36 | — |
| Expensive | 26x | $115 | +22% |
Historical ranges are pointers, not guarantees.
BABA's PE is 21x, but its earnings don't support one, so it isn't a reliable read right now.
FIGS PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 48x | $18.14 | -20% |
| Forward | 57x | $22.68 | — |
| Current | 60x | $22.68 | — |
| Fair | 86x | $32.55 | +43% |
| Expensive | 177x | $67.36 | +197% |
Historical ranges are pointers, not guarantees.
FIGS has the edge over BABA in the historical PE scenario, which offers more potential upside but is not a forecast.
BABA Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Strong growth | |
| Growth | |
| Strongly improving | |
| Limited | |
| Low |
Analysts expect earnings and revenue growth for BABA, with profitability improving. However, they disagree widely on these estimates.
FIGS Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Strong growth | |
| Strong growth | |
| Strongly improving | |
| Limited | |
| Low |
Analysts expect strong earnings and revenue growth for FIGS, with profitability improving. However, they disagree widely on these estimates.
BABA Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q2 2026 | $4.42 | -52% |
| Q1 2026 | $6.57 | -18% |
| Q4 2025 | $5.79 | -22% |
| Q3 2025 | $7.85 | +49% |
| Q2 2025 | $9.27 | +116% |
| Q1 2025 | $8.06 | +71% |
| Q4 2024 | $7.47 | +24% |
| Q3 2024 | $5.26 | -35% |
BABA's earnings per share have fallen from their peak: $4.42 over the past year, against $9.27 in mid-2025. Its recent earnings include one-off gains.
FIGS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $0.40 | +5.3% |
| Q3 2026 | $0.38 | +280% |
| Q2 2026 | $0.33 | +725% |
| Q1 2026 | $0.22 | +2100% |
| Q4 2025 | $0.19 | +850% |
| Q3 2025 | $0.10 | +43% |
| Q2 2025 | $0.04 | -64% |
| Q1 2025 | $0.01 | -92% |
| Q4 2024 | $0.02 | -83% |
FIGS has the edge over BABA on earnings, with more consistent year-over-year improvement.
BABA Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $40.2B | +8.3% |
| Q1 2026 | $36.5B | +2.9% |
| Q4 2025 | $42.7B | +1.7% |
| Q3 2025 | $37.2B | +4.8% |
| Q2 2025 | $37.2B | +1.8% |
| Q1 2025 | $35.5B | +6.6% |
| Q4 2024 | $42B | +7.6% |
| Q3 2024 | $35.5B | +5.2% |
BABA's revenue has grown year over year for 16 quarters in a row: $40.2B last quarter, up 8.3% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | 7.2% | -6.9 points |
| Q1 2026 | -0.3% | -12 points |
| Q4 2025 | 7.1% | -7.6 points |
| Q3 2025 | 2.2% | -13 points |
| Q2 2025 | 14% | -0.7 points |
| Q1 2025 | 12% | +5.4 points |
| Q4 2024 | 15% | +6.1 points |
| Q3 2024 | 15% | 0 points |
BABA's operating margin was 7.2% last quarter, down 6.9 points from the same quarter a year ago.
FIGS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $190.7M | +26% |
| Q2 2026 | $196.6M | +29% |
| Q1 2026 | $159.9M | +28% |
| Q4 2025 | $201.9M | +33% |
| Q3 2025 | $151.7M | +8.2% |
| Q2 2025 | $152.6M | +5.8% |
| Q1 2025 | $124.9M | +4.7% |
| Q4 2024 | $151.8M | +4.8% |
FIGS has the edge over BABA on sales, with stronger typical year-over-year growth.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 12% | +5.3 points |
| Q2 2026 | 18% | +11 points |
| Q1 2026 | 2.8% | +3 points |
| Q4 2025 | 9.3% | +3.5 points |
| Q3 2025 | 6.3% | +13 points |
| Q2 2025 | 6.5% | +5.4 points |
| Q1 2025 | -0.2% | -0.5 points |
| Q4 2024 | 5.9% | -4 points |
FIGS has the edge over BABA on profitability, with a higher operating margin.
BABA Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | -$6.7B | -$4.1B |
| Q1 2026 | -$2.7B | +$1.5B |
| Q4 2025 | $1B | -90% |
| Q3 2025 | -$3.2B | -254% |
| Q2 2025 | -$2.7B | -182% |
| Q1 2025 | -$4.2B | -12231% |
| Q4 2024 | $10.4B | -4.8% |
| Q3 2024 | $2.1B | -62% |
BABA's free cash flow has turned negative after years in the green: −$11.6B over the past year.
FIGS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $51.2M | +9538% |
| Q2 2026 | $44.3M | +$57.8M |
| Q1 2026 | -$5.6M | -171% |
| Q4 2025 | $58.1M | +115% |
| Q3 2025 | $531K | -97% |
| Q2 2025 | -$13.5M | -279% |
| Q1 2025 | $7.9M | -29% |
| Q4 2024 | $27.1M | +98% |
FIGS has the edge over BABA on cash generation, producing positive trailing cash flow while its opponent burns cash.
BABA Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.5% | +11.1M shares |
| 1 year | +0.9% | +21.4M shares |
| 3 years | -6.2% | -161M shares |
| 5 years | -12% | -339M shares |
| Available history | -8.4% | -221M shares |
BABA has the edge over FIGS on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q2 2026 | — |
| Q1 2026 | — |
| Q4 2025 | — |
| Q3 2025 | $269.8M |
| Q2 2025 | — |
| Q1 2025 | — |
| Q4 2024 | — |
| Q3 2024 | — |
BABA spent $270M buying back its own shares over the past year, after none the year before.
FIGS Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -1% | -1.9M shares |
| 1 year | +6.9% | +12.4M shares |
| 3 years | +6.5% | +11.8M shares |
| 5 years | +23% | +36.4M shares |
| Available history | +21% | +33.1M shares |
FIGS has 193M diluted shares, up 6.9% from a year ago, despite $47M in buybacks over the past year.
| Quarter | Spent |
|---|---|
| Q3 2026 | $13.8M |
| Q2 2026 | $24M |
| Q1 2026 | $8.8M |
| Q4 2025 | — |
| Q3 2025 | — |
| Q2 2025 | — |
| Q1 2025 | $2.7M |
| Q4 2024 | $38.2M |
FIGS spent $47M buying back its own shares over the past year, up 14% from the year before.
BABA Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q2 2026 | 0.5x | Very low |
| Q1 2026 | 0.5x | Very low |
| Q4 2025 | 0.6x | Very low |
| Q3 2025 | 0.8x | Very low |
| Q2 2025 | 0.2x | Very low |
| Q1 2025 | 0.3x | Very low |
| Q4 2024 | 0.1x | Very low |
| Q3 2024 | -0.2x | Net Cash |
BABA's net debt is less than a year of its operating earnings (EBITDA).
FIGS Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -0.8x | Net Cash |
| Q2 2026 | -1.4x | Net Cash |
| Q1 2026 | -1.4x | Net Cash |
| Q4 2025 | -1.7x | Net Cash |
| Q3 2025 | -1.3x | Net Cash |
| Q2 2025 | -2.7x | Net Cash |
| Q1 2025 | -9.5x | Net Cash |
| Q4 2024 | -9.6x | Net Cash |
FIGS has the edge over BABA on leverage, with a lower net debt burden relative to earnings.
BABA Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 38.0 | Neutral |
| Stochastic | 12.7 | Oversold |
BABA's weekly RSI is 38 (neutral) and its Stochastic is 13 (oversold).
FIGS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 73.3 | Overbought |
| Stochastic | 87.1 | Overbought |
FIGS's weekly RSI is 73 (overbought) and its Stochastic is 87 (overbought).
BABA PE vs Consumer Cyclical Sector
| Metric | BABA | Sector median | Relative |
|---|---|---|---|
| PE | 21x | 18x | 19% above |
| PE % | 60 | 47 | 13 pts above |
BABA has the edge over FIGS on valuation relative to its sector.
FIGS PE vs Consumer Cyclical Sector
| Metric | FIGS | Sector median | Relative |
|---|---|---|---|
| PE | 60x | 18x | 231% above |
| PE % | 32 | 54 | 22 pts below |
FIGS is trading at 60x earnings, a 231% premium to the Consumer Cyclical sector's median of 18x.
BABA Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $104.7 | 9.9% below |
| 20 week MA | $111.1 | 15% below |
| 50 week MA | $128.0 | 26% below |
| 100 week MA | $127.7 | 26% below |
| 200 week MA | $106.4 | 11% below |
BABA is in a downtrend: it's below all five of its weekly moving averages, and 11% below its 200-week average.
FIGS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $18.2 | 24% above |
| 20 week MA | $14.8 | 53% above |
| 50 week MA | $13.6 | 67% above |
| 100 week MA | $9.82 | 131% above |
| 200 week MA | $8.09 | 180% above |
FIGS has the edge over BABA on trend strength, trading above more of its moving averages.
BABA Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $215.5 | $222.0 | +3% |
| 2021 | $222.0 | $118.7 | -47% |
| 2022 | $118.7 | $85.7 | -28% |
| 2023 | $85.7 | $77.5 | -9.5% |
| 2024 | $77.5 | $85.1 | +9.7% |
| 2025 | $85.1 | $152.2 | +79% |
| 2026 YTD | $152.2 | $94.4 | -38% |
BABA has finished lower in three of the last six years. It's down 38% so far in 2026.
FIGS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2021 | $34.2 | $26.4 | -23% |
| 2022 | $26.4 | $6.72 | -75% |
| 2023 | $6.72 | $6.95 | +3.4% |
| 2024 | $6.95 | $6.01 | -14% |
| 2025 | $6.01 | $11.8 | +97% |
| 2026 YTD | $11.8 | $22.7 | +92% |
FIGS has the edge over BABA on returns for 2026, with the stronger performance.